These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10528815)

  • 21. Presence and characterization of the serotonin transporter in human resting lymphocytes.
    Marazziti D; Rossi A; Giannaccini G; Baroni S; Lucacchini A; Cassano GB
    Neuropsychopharmacology; 1998 Aug; 19(2):154-9. PubMed ID: 9629569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin transporter gene polymorphisms and platelet [3H] paroxetine binding in premenstrual dysphoria.
    Melke J; Westberg L; Landén M; Sundblad C; Eriksson O; Baghei F; Rosmond R; Eriksson E; Ekman A
    Psychoneuroendocrinology; 2003 Apr; 28(3):446-58. PubMed ID: 12573307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methodologic pitfalls in measurement of 5-hydroxytriptamine uptake transporters in human platelets by [3H]-paroxetine binding assay.
    Jurado N; Torner C; Heinze G; López G; Mendoza-Sotelo J; Lazo-Langner A; Moreno J
    Arch Med Res; 2003; 34(5):422-7. PubMed ID: 14602510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding.
    Wihlbäck AC; Sundström Poromaa I; Bixo M; Allard P; Mjörndal T; Spigset O
    Psychoneuroendocrinology; 2004 Jul; 29(6):757-66. PubMed ID: 15110925
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
    Béïque JC; Lavoie N; de Montigny C; Debonnel G
    Eur J Pharmacol; 1998 May; 349(1):129-32. PubMed ID: 9669506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxetine.
    Naylor L; Dean B; Opeskin K; Pavey G; Hill C; Keks N; Copolov D
    J Neural Transm (Vienna); 1996; 103(6):749-57. PubMed ID: 8836936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased density of the platelet serotonin transporter in autism.
    Marazziti D; Muratori F; Cesari A; Masala I; Baroni S; Giannaccini G; Dell'Osso L; Cosenza A; Pfanner P; Cassano GB
    Pharmacopsychiatry; 2000 Sep; 33(5):165-8. PubMed ID: 11071017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
    Spigset O; Allard P; Mjörndal T
    Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains.
    Rosel P; Arranz B; Vallejo J; Oros M; Menchón JM; Alvarez P; Navarro MA
    J Neural Transm (Vienna); 1997; 104(8-9):921-9. PubMed ID: 9451724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of [3H]paroxetine to platelets of depressed patients: seasonal differences and effects of diagnostic classification.
    D'Hondt P; Maes M; Leysen JE; Gommeren W; Scharpé S; Cosyns P
    J Affect Disord; 1994 Sep; 32(1):27-35. PubMed ID: 7798464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of serotonin transporter in goldfish retina by the binding of [3H]paroxetine and the uptake of [3H]serotonin: modulation by light.
    Lima L; Schmeer C
    J Neurochem; 1994 Feb; 62(2):528-35. PubMed ID: 8294915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers.
    Patkar AA; Gopalakrishnan R; Berrettini WH; Weinstein SP; Vergare MJ; Leone FT
    Psychopharmacology (Berl); 2003 Mar; 166(3):221-7. PubMed ID: 12589524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
    Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
    Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serotonin transporter and MAO-B levels in monoamine nuclei of the human brainstem are normal in major depression.
    Klimek V; Roberson G; Stockmeier CA; Ordway GA
    J Psychiatr Res; 2003; 37(5):387-97. PubMed ID: 12849931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging, estradiol and time of day differentially affect serotonin transporter binding in the central nervous system of female rats.
    Krajnak K; Rosewell KL; Duncan MJ; Wise PM
    Brain Res; 2003 Nov; 990(1-2):87-94. PubMed ID: 14568333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
    Watanabe Y; Sakai RR; McEwen BS; Mendelson S
    Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
    Goto S; Egashira T; Wada Y; Takayama F; Yamanaka Y
    Jpn J Pharmacol; 1996 Aug; 71(4):291-8. PubMed ID: 8886926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet serotonergic functions and light therapy in seasonal affective disorder.
    Stain-Malmgren R; Kjellman BF; Aberg-Wistedt A
    Psychiatry Res; 1998 May; 78(3):163-72. PubMed ID: 9657420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting treatment-outcome in cocaine dependence from admission urine drug screen and peripheral serotonergic measures.
    Patkar AA; Thornton CC; Berrettini WH; Gottheil E; Weinstein SP; Hill KP
    J Subst Abuse Treat; 2002 Jul; 23(1):33-40. PubMed ID: 12127466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.